Indegene Intrinsic Value
Indegene (INDGN) median intrinsic value is ₹800.00 from 10 valuation models (range ₹148–₹1232), vs current price ₹492.65 — +62.4% upside (Trading Below Calculated Value), margin of safety 38.4%. Read INDGN dividend payout details for the complete payout history and dividend yield track record.
INDGN Valuation Methods Summary — DCF, Graham Number & P/E
Indegene intrinsic value across 10 models vs current price ₹492.65 — upside/downside and value range per method. Analyse INDGN shareholder distribution to track promoter, FII and institutional holdings.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹292.16 | ₹233.73 - ₹350.59 | -40.7% | EPS: ₹13.28, Sector P/E: 22x |
| Book Value Method | asset | ₹1231.62 | ₹1108.46 - ₹1354.78 | +150.0% | Book Value/Share: ₹653.96, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹985.30 | ₹886.77 - ₹1083.83 | +100.0% | Revenue/Share: ₹845.00, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹985.30 | ₹886.77 - ₹1083.83 | +100.0% | EBITDA: ₹616.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹1231.62 | ₹985.30 - ₹1477.94 | +150.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹147.79 | ₹133.01 - ₹162.57 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹205.18 | ₹184.66 - ₹225.70 | -58.4% | Revenue Growth: 6.0%, Adj P/E: 15.5x |
| ROE Based Valuation | profitability | ₹800.00 | ₹720.00 - ₹880.00 | +62.4% | ROE: 10.2%, P/E Multiple: 12x |
| Graham Defensive Method | conservative | ₹442.04 | ₹397.84 - ₹486.24 | -10.3% | EPS: ₹13.28, BVPS: ₹653.96 |
| Dividend Yield Method | dividend | ₹147.79 | ₹133.01 - ₹162.57 | -70.0% | DPS: ₹2.25, Target Yield: 2.5% |
INDGN Intrinsic Value vs Market Price — All Valuation Models
Indegene fair value range ₹148–₹1232 vs current market price ₹492.65 across 10 valuation models. For current market price and key ratios, visit Indegene share price chart.
INDGN Intrinsic Value Analysis — Undervalued or Overvalued?
Indegene median intrinsic value ₹800.00, current price ₹492.65 — Trading Below Calculated Value by 62.4%, margin of safety 38.4%.
What is the intrinsic value of INDGN?
Based on our comprehensive analysis using 10 different valuation methods, the estimated intrinsic value of Indegene (INDGN) is ₹800.00 (median value). With the current market price of ₹492.65, this represents a +62.4% variance from our estimated fair value.
The valuation range spans from ₹147.79 to ₹1231.62, indicating ₹147.79 - ₹1231.62.
Is INDGN undervalued or overvalued?
Based on our multi-method analysis, Indegene (INDGN) appears to be trading below calculated value by approximately 62.4%.
INDGN Financial Health — Key Ratios vs Industry Benchmarks
Indegene financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 6.63 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 10.2% | Industry Standard: 15%+ | Above 10% | Measures shareholder return efficiency |
| Operating Margin | 14.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.88x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
INDGN Cash Flow Quality — Operating & Free Cash Flow
Indegene operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹442 Cr | ₹104 Cr | Positive Free Cash Flow | 7/10 |
| March 2024 | ₹508 Cr | ₹345 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹130 Cr | ₹-318 Cr | Positive Operating Cash Flow | 6/10 |
| March 2022 | ₹297 Cr | ₹218 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹172 Cr | ₹132 Cr | Positive Free Cash Flow | 8/10 |